Apellis Pharmaceuticals Inc (NASDAQ: APLS) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Apellis Pharmaceuticals Inc is $4.98B. A total of 0.72 million shares were traded on the day, compared to an average of 1.39M shares.

In the most recent transaction, Deschatelets Pascal sold 78,907 shares of APLS for 42.35 per share on May 08 ’24. After the transaction, the Chief Scientific Officer now owns 1,115,983 company shares. In a previous transaction on Apr 08 ’24, Deschatelets Pascal sold 69,107 shares at 54.17 per share. APLS shares that Chief Scientific Officer owns now total 1,115,983.

Among the insiders who sold shares, Sullivan Timothy Eugene disposed of 4,000 shares on Apr 01 ’24 at a per-share price of $58.66. This resulted in the Chief Financial Officer holding 93,338 shares of APLS after the transaction. In another insider transaction, Dunlop A. Sinclair sold 18,681 shares at $57.18 per share on Mar 19 ’24. Company shares held by the Director now total 173,998.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, APLS has a high of $94.75 and a low of $19.83.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $2.20, while its Total Shareholder’s Equity was $198.66M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.47.

Most Popular

Related Posts